1. Multicenter Study Group; From the Departments of Urology, New York University and Columbia University, and Pfizer Central Research, New York, New York, Urology Center of Florida, Ocala, Florida, Memorial Hospital, Houston, Texas, and Department of Urology, Louisiana State University Medical Center, New Orleans, Louisiana.